Please see information below and attached for a webinar on December 12th describing the differences between lobbying and advocacy. There are often misconceptions about the two, so all are encouraged to attend!
Karen
Hello CCCNP! We are glad to share this webinar opportunity featuring two national partner colleagues. Feel free to promote through your networks!
Dear cancer control colleagues,
As a training and technical assistance provider of the Centers for Disease Control and Prevention (CDC) National Comprehensive Cancer Control Program, the American Cancer Society is proud to present a webinar entitled, "Advocacy vs Lobbying: What's the Difference?".
Cancer coalitions strive to develop data-driven, evidence-based policy agendas that are feasible based on local political context and cultural preferences. Yet sometimes partners within a coalition are hesitant to fully participate in advocacy. Join us on December 12th (3:00pm-4:00pm EST) to hear from two leading experts who will discuss the difference between advocacy and lobbying; how to identify and utilize effective messaging strategies; and identifying data sources that can support advocacy efforts in cancer control.
We have attached ready-to-go graphics and materials for you to share on social media, newsletters and in other communications with your cancer coalition partners. You can also cut/paste the email content provided below.
Together, we can make a meaningful impact in the fight against cancer.
Warm regards,
Katie Bathje
________________
ACS Webinar Opportunity: Calling all cancer coalition partners!
Advocacy vs Lobbying: What's the Difference?
- Dec. 12th, 2024 (3:00 PM- 4:00 PM EST)
- Promotional Flier HERE (Attached: Sell sheet flier, 2 LinkedIn PNG's, Email header)
- Register today HERE
Guest Speakers:
- Rebecca Birch, Director, State Policy & Advocacy Susan G. Komen®
- Deanna Henkle, MSW, BA, ACS Cancer Action Network (ACS CAN), Senior State & Local Campaigns Manager – Prevention
After participating in this webinar, coalitions and their stakeholders will be able to:
· Describe the difference between advocacy and lobbying
· Discuss how to identify and utilize effective messaging strategies for cancer control advocacy
· Identify data sources that can support advocacy efforts in cancer control
| Katie Bathje | Strategic Director, Comprehensive Cancer Control Initiatives |
| American Cancer Society, Inc. |
| 270 Peachtree Street NW Suite 1300 |
| Atlanta, GA 30303 |
| Phone: +1 (502) 2135845 |
| cancer.org | 1.800.227.2345 |
| This message (including any attachments) is intended exclusively for the individual to whom it is addressed and may contain proprietary, protected, or confidential information. If you are not the named addressee, you are not authorized to read, print, copy, or disseminate this message or any part of it. If you have received this message in error, please notify the sender immediately. |